Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellectis S.A., a foreign private issuer, on June 29, 2018. The report serves to update the Company's Bylaws following amendments adopted at the Combined Ordinary and Extraordinary Meeting held on June 26, 2018.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance update and does not contain financial performance data.
Material Changes
The primary material change reported is the restatement of the Company's Bylaws to incorporate amendments previously adopted and reported on June 26, 2018. The updated Bylaws are filed as Exhibit 99.1.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is strictly a procedural filing to incorporate the updated Bylaws by reference into the Company's registration statements on Forms F-3 and S-8.
Key Facts for Investor Verification
- Verify the specific amendments to the Bylaws by reviewing Exhibit 99.1 attached to this filing.
- Confirm that the updated Bylaws are now incorporated by reference into the Company's active registration statements (Forms F-3 and S-8).
- Note that this filing does not contain financial results; refer to the most recent Form 20-F or quarterly reports for financial data.